Literature DB >> 27796285

IL-17A ≠ Th17 in GvHD.

Yongxia Wu1, Xue-Zhong Yu1,2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27796285      PMCID: PMC5843611          DOI: 10.1038/cmi.2016.54

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  15 in total

1.  Attenuation of acute graft-versus-host disease in the absence of the transcription factor RORγt.

Authors:  LeShara M Fulton; Michael J Carlson; James M Coghill; Laura E Ott; Michelle L West; Angela Panoskaltsis-Mortari; Dan R Littman; Bruce R Blazar; Jonathan S Serody
Journal:  J Immunol       Date:  2012-07-09       Impact factor: 5.422

Review 2.  IL-17 and Th17 Cells.

Authors:  Thomas Korn; Estelle Bettelli; Mohamed Oukka; Vijay K Kuchroo
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

3.  Adoptively transferred donor IL-17-producing CD4+ T cells augment, but IL-17 alleviates, acute graft-versus-host disease.

Authors:  Yifeng Cai; Shoubao Ma; Yuejun Liu; Huanle Gong; Qiao Cheng; Bo Hu; Yan Wu; Xiao Yu; Chen Dong; Kai Sun; Depei Wu; Haiyan Liu
Journal:  Cell Mol Immunol       Date:  2016-10-17       Impact factor: 11.530

4.  In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations.

Authors:  Michael J Carlson; Michelle L West; James M Coghill; Angela Panoskaltsis-Mortari; Bruce R Blazar; Jonathan S Serody
Journal:  Blood       Date:  2008-10-28       Impact factor: 22.113

5.  Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease.

Authors:  Tangsheng Yi; Dongchang Zhao; Chia-Lei Lin; Chunyan Zhang; Ying Chen; Ivan Todorov; Thomas LeBon; Fouad Kandeel; Stephen Forman; Defu Zeng
Journal:  Blood       Date:  2008-07-02       Impact factor: 22.113

6.  Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease.

Authors:  Alan M Hanash; Jarrod A Dudakov; Guoqiang Hua; Margaret H O'Connor; Lauren F Young; Natalie V Singer; Mallory L West; Robert R Jenq; Amanda M Holland; Lucy W Kappel; Arnab Ghosh; Jennifer J Tsai; Uttam K Rao; Nury L Yim; Odette M Smith; Enrico Velardi; Elena B Hawryluk; George F Murphy; Chen Liu; Lynette A Fouser; Richard Kolesnick; Bruce R Blazar; Marcel R M van den Brink
Journal:  Immunity       Date:  2012-08-24       Impact factor: 31.745

7.  IL-17 contributes to CD4-mediated graft-versus-host disease.

Authors:  Lucy W Kappel; Gabrielle L Goldberg; Christopher G King; David Y Suh; Odette M Smith; Cassandra Ligh; Amanda M Holland; Jeremy Grubin; Nicholas M Mark; Chen Liu; Yoichiro Iwakura; Glenn Heller; Marcel R M van den Brink
Journal:  Blood       Date:  2008-10-17       Impact factor: 22.113

8.  T helper17 cells are sufficient but not necessary to induce acute graft-versus-host disease.

Authors:  Cristina Iclozan; Yu Yu; Chen Liu; Yaming Liang; Tangsheng Yi; Claudio Anasetti; Xue-Zhong Yu
Journal:  Biol Blood Marrow Transplant       Date:  2009-10-02       Impact factor: 5.742

9.  TH17 Cells in Autoimmunity and Immunodeficiency: Protective or Pathogenic?

Authors:  Ashish K Marwaha; Nicole J Leung; Alicia N McMurchy; Megan K Levings
Journal:  Front Immunol       Date:  2012-06-04       Impact factor: 7.561

10.  Regulation of inflammatory responses by IL-17F.

Authors:  Xuexian O Yang; Seon Hee Chang; Heon Park; Roza Nurieva; Bhavin Shah; Luis Acero; Yi-Hong Wang; Kimberly S Schluns; Russell R Broaddus; Zhou Zhu; Chen Dong
Journal:  J Exp Med       Date:  2008-04-14       Impact factor: 14.307

View more
  1 in total

Review 1.  Recent advances in our understanding of the allograft response.

Authors:  Conor Hennessy; Guido Lewik; Amy Cross; Joanna Hester; Fadi Issa
Journal:  Fac Rev       Date:  2021-02-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.